Enzymes catalyzing ubiquitination and proteolytic processing of the p105 precursor of nuclear factor κB1

被引:56
作者
Coux, O [1 ]
Goldberg, AL [1 ]
机构
[1] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA
关键词
D O I
10.1074/jbc.273.15.8820
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nuclear factor kappa B1 (NF-kappa B) is a heterodimeric complex that regulates transcription of many genes involved in immune and inflammatory responses. Its 50-kDa subunit (p50) is generated by the ubiquitin-proteasome pathway from a 105-kDa precursor (p105). We have reconstituted this proteolytic process in HeLa cell extracts and purified the responsible enzymes. Ubiquitination of p105 requires El, and either of two types of E2s, E2-25K (for which p105 is the first proven substrate) or a member of the UBCH5 (UBC4) family. It also requires a new E3 of 50 kDa, which we call E3 kappa B. This set of enzymes differs from the E2s and E3 reported by others to catalyze p105 ubiquitination in reticulocytes. The ubiquitinating enzymes purified here, together with 26S proteasomes, allowed formation of p50. Thus, the 26S proteasome provides all the proteolytic activities necessary for p105 processing. Interestingly, in the reconstituted system, as observed in cells, the C-terminally truncated form of p105, p97, was processed into p50 more efficiently than normal p105, even when both species were ubiquitinated to a similar extent. Therefore, some additional mechanism involving the C-terminal region of p105 influences the proteolytic processing of the ubiquitinated precursor.
引用
收藏
页码:8820 / 8828
页数:9
相关论文
共 58 条
  • [1] Processive degradation of proteins and other catalytic properties of the proteasome from Thermoplasma acidophilum
    Akopian, TN
    Kisselev, AF
    Goldberg, AL
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (03) : 1791 - 1798
  • [2] E2-C, a cyclin-selective ubiquitin carrier protein required for the destruction of mitotic cyclins
    Aristarkhov, A
    Eytan, E
    Moghe, A
    Admon, A
    Hershko, A
    Ruderman, JV
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (09) : 4294 - 4299
  • [3] NF-kappa B: Ten years after
    Baeuerle, PA
    Baltimore, D
    [J]. CELL, 1996, 87 (01) : 13 - 20
  • [4] BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141
  • [5] I-KAPPA-B - A SPECIFIC INHIBITOR OF THE NF-KAPPA-B TRANSCRIPTION FACTOR
    BAEUERLE, PA
    BALTIMORE, D
    [J]. SCIENCE, 1988, 242 (4878) : 540 - 546
  • [6] BEERS EP, 1993, J BIOL CHEM, V268, P21645
  • [7] I-KAPPA-B INTERACTS WITH THE NUCLEAR-LOCALIZATION SEQUENCES OF THE SUBUNITS OF NF-KAPPA-B - A MECHANISM FOR CYTOPLASMIC RETENTION
    BEG, AA
    RUBEN, SM
    SCHEINMAN, RI
    HASKILL, S
    ROSEN, CA
    BALDWIN, AS
    [J]. GENES & DEVELOPMENT, 1992, 6 (10) : 1899 - 1913
  • [8] CYTOPLASMIC RETENTION, DNA-BINDING AND PROCESSING OF THE NF-KAPPA-B P50 PRECURSOR ARE CONTROLLED BY A SMALL REGION IN ITS C-TERMINUS
    BLANK, V
    KOURILSKY, P
    ISRAEL, A
    [J]. EMBO JOURNAL, 1991, 10 (13) : 4159 - 4167
  • [9] CENTRAL OF I-KAPPA-B-ALPHA PROTEOLYSIS BY SITE-SPECIFIC, SIGNAL-INDUCED PHOSPHORYLATION
    BROWN, K
    GERSTBERGER, S
    CARLSON, L
    FRANZOSO, G
    SIEBENLIST, U
    [J]. SCIENCE, 1995, 267 (5203) : 1485 - 1488
  • [10] CHEN ZJ, 1990, J BIOL CHEM, V265, P21835